Cronos Group Inc. (CRON)
NASDAQ: CRON · Real-Time Price · USD
1.970
+0.030 (1.55%)
At close: Feb 21, 2025, 4:00 PM
1.960
-0.010 (-0.51%)
After-hours: Feb 21, 2025, 7:18 PM EST
Cronos Group Market Cap
Cronos Group has a market cap or net worth of $748.14 million as of February 21, 2025. Its market cap has decreased by -4.24% in one year.
Market Cap
748.14M
Enterprise Value
-22.58M
1-Year Change
-4.24%
Ranking
Category
Stock Price
$1.97
Market Cap Chart
Since February 27, 2018, Cronos Group's market cap has decreased from $1.14B to $748.14M, a decrease of -34.26%. That is a compound annual growth rate of -5.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2025 | 741.70M | -3.95% |
| Dec 31, 2024 | 772.20M | -3.05% |
| Dec 29, 2023 | 796.50M | -17.14% |
| Dec 30, 2022 | 961.30M | -34.04% |
| Dec 31, 2021 | 1.46B | -41.04% |
| Dec 31, 2020 | 2.47B | -6.25% |
| Dec 31, 2019 | 2.64B | 42.01% |
| Dec 31, 2018 | 1.86B | 63.14% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |